CRANE CO (CR) Fundamental Analysis & Valuation

NYSE:CR • US2244081046

Current stock price

174.93 USD
-2.8 (-1.58%)
Last:

This CR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CR Profitability Analysis

1.1 Basic Checks

  • CR had positive earnings in the past year.
  • CR had a positive operating cash flow in the past year.
  • In the past 5 years CR has always been profitable.
  • CR had a positive operating cash flow in 4 of the past 5 years.
CR Yearly Net Income VS EBIT VS OCF VS FCFCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.51%, CR belongs to the top of the industry, outperforming 82.44% of the companies in the same industry.
  • The Return On Equity of CR (17.79%) is better than 83.97% of its industry peers.
  • The Return On Invested Capital of CR (9.76%) is better than 72.52% of its industry peers.
  • CR had an Average Return On Invested Capital over the past 3 years of 11.11%. This is in line with the industry average of 10.06%.
Industry RankSector Rank
ROA 9.51%
ROE 17.79%
ROIC 9.76%
ROA(3y)10.52%
ROA(5y)11.62%
ROE(3y)18.21%
ROE(5y)23.2%
ROIC(3y)11.11%
ROIC(5y)9.19%
CR Yearly ROA, ROE, ROICCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • With an excellent Profit Margin value of 15.90%, CR belongs to the best of the industry, outperforming 90.84% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CR has grown nicely.
  • CR's Operating Margin of 18.40% is amongst the best of the industry. CR outperforms 85.50% of its industry peers.
  • CR's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 42.20%, CR is in the better half of the industry, outperforming 79.39% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CR has grown nicely.
Industry RankSector Rank
OM 18.4%
PM (TTM) 15.9%
GM 42.2%
OM growth 3Y24.93%
OM growth 5Y11.9%
PM growth 3Y-11.02%
PM growth 5Y20.88%
GM growth 3Y4.28%
GM growth 5Y4.26%
CR Yearly Profit, Operating, Gross MarginsCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. CR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CR is creating some value.
  • CR has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CR has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CR has a worse debt to assets ratio.
CR Yearly Shares OutstandingCR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CR Yearly Total Debt VS Total AssetsCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • CR has an Altman-Z score of 5.61. This indicates that CR is financially healthy and has little risk of bankruptcy at the moment.
  • CR has a better Altman-Z score (5.61) than 80.15% of its industry peers.
  • The Debt to FCF ratio of CR is 3.36, which is a good value as it means it would take CR, 3.36 years of fcf income to pay off all of its debts.
  • CR's Debt to FCF ratio of 3.36 is fine compared to the rest of the industry. CR outperforms 63.36% of its industry peers.
  • A Debt/Equity ratio of 0.56 indicates that CR is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.56, CR is in line with its industry, outperforming 40.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 3.36
Altman-Z 5.61
ROIC/WACC0.95
WACC10.27%
CR Yearly LT Debt VS Equity VS FCFCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 5.53 indicates that CR has no problem at all paying its short term obligations.
  • CR's Current ratio of 5.53 is amongst the best of the industry. CR outperforms 92.37% of its industry peers.
  • CR has a Quick Ratio of 4.72. This indicates that CR is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 4.72, CR belongs to the best of the industry, outperforming 92.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.53
Quick Ratio 4.72
CR Yearly Current Assets VS Current LiabilitesCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 18.20% over the past year.
  • The Earnings Per Share has been growing by 9.48% on average over the past years. This is quite good.
  • CR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.16%.
  • Measured over the past years, CR shows a decrease in Revenue. The Revenue has been decreasing by -4.73% on average per year.
EPS 1Y (TTM)18.2%
EPS 3Y-7.77%
EPS 5Y9.48%
EPS Q2Q%18.71%
Revenue 1Y (TTM)8.16%
Revenue growth 3Y9.07%
Revenue growth 5Y-4.73%
Sales Q2Q%24.89%

3.2 Future

  • CR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.29% yearly.
  • CR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.32% yearly.
EPS Next Y13.91%
EPS Next 2Y13.43%
EPS Next 3Y13.69%
EPS Next 5Y12.29%
Revenue Next Year24.84%
Revenue Next 2Y14.89%
Revenue Next 3Y11.44%
Revenue Next 5Y9.32%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CR Yearly Revenue VS EstimatesCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
CR Yearly EPS VS EstimatesCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

3

4. CR Valuation Analysis

4.1 Price/Earnings Ratio

  • CR is valuated quite expensively with a Price/Earnings ratio of 27.77.
  • CR's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of CR to the average of the S&P500 Index (26.77), we can say CR is valued inline with the index average.
  • A Price/Forward Earnings ratio of 22.51 indicates a rather expensive valuation of CR.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CR.
  • The average S&P500 Price/Forward Earnings ratio is at 21.75. CR is around the same levels.
Industry RankSector Rank
PE 27.77
Fwd PE 22.51
CR Price Earnings VS Forward Price EarningsCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CR is valued a bit more expensive than the industry average as 64.89% of the companies are valued more cheaply.
  • CR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 29.59
EV/EBITDA 22.98
CR Per share dataCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CR does not grow enough to justify the current Price/Earnings ratio.
  • CR has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CR's earnings are expected to grow with 13.69% in the coming years.
PEG (NY)2
PEG (5Y)2.93
EPS Next 2Y13.43%
EPS Next 3Y13.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CR Dividend Analysis

5.1 Amount

  • CR has a yearly dividend return of 0.55%, which is pretty low.
  • CR's Dividend Yield is comparable with the industry average which is at 1.13.
  • Compared to an average S&P500 Dividend Yield of 1.82, CR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

  • The dividend of CR decreases each year by -11.69%.
  • CR has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of CR decreased recently.
Dividend Growth(5Y)-11.69%
Div Incr Years1
Div Non Decr Years1
CR Yearly Dividends per shareCR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • CR pays out 14.43% of its income as dividend. This is a sustainable payout ratio.
DP14.43%
EPS Next 2Y13.43%
EPS Next 3Y13.69%
CR Yearly Income VS Free CF VS DividendCR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M
CR Dividend Payout.CR Dividend Payout, showing the Payout Ratio.CR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CR Fundamentals: All Metrics, Ratios and Statistics

CRANE CO

NYSE:CR (5/1/2026, 2:02:49 PM)

174.93

-2.8 (-1.58%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Industry Strength61.49
Industry Growth56.52
Earnings (Last)04-27
Earnings (Next)07-27
Inst Owners76.61%
Inst Owner Change0.51%
Ins Owners0.29%
Ins Owner Change0.48%
Market Cap10.10B
Revenue(TTM)2.31B
Net Income(TTM)366.60M
Analysts83.33
Price Target221.37 (26.55%)
Short Float %1.64%
Short Ratio1.77
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly Dividend0.92
Dividend Growth(5Y)-11.69%
DP14.43%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.03%
Min EPS beat(2)5.05%
Max EPS beat(2)7.02%
EPS beat(4)4
Avg EPS beat(4)5.79%
Min EPS beat(4)3.28%
Max EPS beat(4)7.79%
EPS beat(8)8
Avg EPS beat(8)3.99%
EPS beat(12)12
Avg EPS beat(12)9.29%
EPS beat(16)15
Avg EPS beat(16)7.78%
Revenue beat(2)0
Avg Revenue beat(2)-1.29%
Min Revenue beat(2)-1.39%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-1.39%
Max Revenue beat(4)-1.18%
Revenue beat(8)1
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-0.77%
Revenue beat(16)5
Avg Revenue beat(16)1.97%
PT rev (1m)-0.81%
PT rev (3m)1.28%
EPS NQ rev (1m)0.1%
EPS NQ rev (3m)-1.59%
EPS NY rev (1m)0.01%
EPS NY rev (3m)0.88%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)6.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)8.5%
Valuation
Industry RankSector Rank
PE 27.77
Fwd PE 22.51
P/S 4.38
P/FCF 29.59
P/OCF 25.58
P/B 4.9
P/tB 8.23
EV/EBITDA 22.98
EPS(TTM)6.3
EY3.6%
EPS(NY)7.77
Fwd EY4.44%
FCF(TTM)5.91
FCFY3.38%
OCF(TTM)6.84
OCFY3.91%
SpS39.92
BVpS35.7
TBVpS21.26
PEG (NY)2
PEG (5Y)2.93
Graham Number71.1333 (-59.34%)
Profitability
Industry RankSector Rank
ROA 9.51%
ROE 17.79%
ROCE 12.52%
ROIC 9.76%
ROICexc 11.47%
ROICexgc 16.14%
OM 18.4%
PM (TTM) 15.9%
GM 42.2%
FCFM 14.81%
ROA(3y)10.52%
ROA(5y)11.62%
ROE(3y)18.21%
ROE(5y)23.2%
ROIC(3y)11.11%
ROIC(5y)9.19%
ROICexc(3y)13.17%
ROICexc(5y)10.95%
ROICexgc(3y)22.21%
ROICexgc(5y)18.82%
ROCE(3y)14.25%
ROCE(5y)11.94%
ROICexgc growth 3Y37.68%
ROICexgc growth 5Y-3.77%
ROICexc growth 3Y36.16%
ROICexc growth 5Y9.91%
OM growth 3Y24.93%
OM growth 5Y11.9%
PM growth 3Y-11.02%
PM growth 5Y20.88%
GM growth 3Y4.28%
GM growth 5Y4.26%
F-Score6
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 3.36
Debt/EBITDA 2.42
Cap/Depr 106.57%
Cap/Sales 2.32%
Interest Coverage 54.38
Cash Conversion 83.22%
Profit Quality 93.1%
Current Ratio 5.53
Quick Ratio 4.72
Altman-Z 5.61
F-Score6
WACC10.27%
ROIC/WACC0.95
Cap/Depr(3y)96.17%
Cap/Depr(5y)95.85%
Cap/Sales(3y)2.04%
Cap/Sales(5y)1.94%
Profit Quality(3y)81.38%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.2%
EPS 3Y-7.77%
EPS 5Y9.48%
EPS Q2Q%18.71%
EPS Next Y13.91%
EPS Next 2Y13.43%
EPS Next 3Y13.69%
EPS Next 5Y12.29%
Revenue 1Y (TTM)8.16%
Revenue growth 3Y9.07%
Revenue growth 5Y-4.73%
Sales Q2Q%24.89%
Revenue Next Year24.84%
Revenue Next 2Y14.89%
Revenue Next 3Y11.44%
Revenue Next 5Y9.32%
EBIT growth 1Y19.22%
EBIT growth 3Y36.25%
EBIT growth 5Y6.6%
EBIT Next Year38%
EBIT Next 3Y18.93%
EBIT Next 5Y14.03%
FCF growth 1Y44.5%
FCF growth 3YN/A
FCF growth 5Y4.38%
OCF growth 1Y44.72%
OCF growth 3YN/A
OCF growth 5Y4.99%

CRANE CO / CR Fundamental Analysis FAQ

What is the fundamental rating for CR stock?

ChartMill assigns a fundamental rating of 6 / 10 to CR.


Can you provide the valuation status for CRANE CO?

ChartMill assigns a valuation rating of 3 / 10 to CRANE CO (CR). This can be considered as Overvalued.


How profitable is CRANE CO (CR) stock?

CRANE CO (CR) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for CR stock?

The Price/Earnings (PE) ratio for CRANE CO (CR) is 27.77 and the Price/Book (PB) ratio is 4.9.


How financially healthy is CRANE CO?

The financial health rating of CRANE CO (CR) is 7 / 10.